Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action SEATTLE, WASHINGTON / ACCESS Newswire / March 18, 2025 / Aptevo Therapeutics , a leader in the ...
Stick formats for makeup & skincare are drawing legions of fans—and here are the packaging suppliers offering eco-friendly & innovative sticks.
The trends on Gift Nifty also indicate a negative start for the Indian benchmark index. The Gift Nifty was trading around ...
The pandemic hit Manchester much like it did elsewhere in the country, and across the world - suddenly and shockingly, ...
EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer ...
Moving on to lab products, which includes PCR kits for rapid disease donor HLA typing and NGS kits for transplant recipient HLA typing globally and IVD monitoring assays for solid organ and stem ...
The Phase III MATTERHORN trial demonstrated that Imfinzi (durvalumab) plus FLOT chemotherapy significantly improved ...
The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback